Literature DB >> 11583116

p90-RSK and Akt may promote rapid phosphorylation/inactivation of glycogen synthase kinase 3 in chemoattractant-stimulated neutrophils.

D D De Mesquita1, Q Zhan, L Crossley, J A Badwey.   

Abstract

Stimulation of neutrophils with the chemoattractant fMet-Leu-Phe (fMLP) triggers phosphorylation/inactivation of the a- and beta-isoforms of glycogen synthase kinase 3 (GSK-3) with phosphorylation of the alpha-isoform predominating. These reactions were monitored with a phosphospecific antibody that only recognized the alpha- or beta-isoforms of GSK-3 when these proteins were phosphorylated on serine residues 21 and 9, respectively. Inhibitor studies indicated that phosphorylation of GSK-3alpha may be catalyzed by the combined action of p90-RSK and Akt and may represent a new strategy by which G protein-coupled receptors inactivate GSK-3. Inactivation of GSK-3 may be one of the mechanisms that delay apoptosis in fMLP-stimulated neutrophils.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583116     DOI: 10.1016/s0014-5793(01)02669-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate.

Authors:  Thomas K Creson; Peixiong Yuan; Husseini K Manji; Guang Chen
Journal:  J Mol Neurosci       Date:  2008-08-03       Impact factor: 3.444

Review 2.  Kinase AKT controls innate immune cell development and function.

Authors:  Yan Zhang; Xiao Wang; Hui Yang; Huanrong Liu; Yun Lu; Limei Han; Guangwei Liu
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

Review 3.  Mcl-1 is vital for neutrophil survival.

Authors:  Mark P Murphy; Emma Caraher
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

Review 4.  GSK3β and the control of infectious bacterial diseases.

Authors:  Huizhi Wang; Akhilesh Kumar; Richard J Lamont; David A Scott
Journal:  Trends Microbiol       Date:  2014-03-04       Impact factor: 17.079

5.  Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cells.

Authors:  Qingding Wang; Yuning Zhou; B Mark Evers
Journal:  Neoplasia       Date:  2006-09       Impact factor: 5.715

Review 6.  A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.

Authors:  Sushmitha S Purushotham; Neeharika M N Reddy; Michelle Ninochka D'Souza; Nilpawan Roy Choudhury; Anusa Ganguly; Niharika Gopalakrishna; Ravi Muddashetty; James P Clement
Journal:  Exp Brain Res       Date:  2022-09-05       Impact factor: 2.064

7.  Targeting Lyn regulates Snail family shuttling and inhibits metastasis.

Authors:  D Thaper; S Vahid; K M Nip; I Moskalev; X Shan; S Frees; M E Roberts; K Ketola; K W Harder; C Gregory-Evans; J L Bishop; A Zoubeidi
Journal:  Oncogene       Date:  2017-03-13       Impact factor: 9.867

8.  Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.

Authors:  Rui Wang; Lijuan Xia; Janice Gabrilove; Samuel Waxman; Yongkui Jing
Journal:  Clin Cancer Res       Date:  2015-10-12       Impact factor: 12.531

9.  Phosphorylation and mRNA splicing of collapsin response mediator protein-2 determine inhibition of rho-associated protein kinase (ROCK) II function in carcinoma cell migration and invasion.

Authors:  Marie Morgan-Fisher; John R Couchman; Atsuko Yoneda
Journal:  J Biol Chem       Date:  2013-09-13       Impact factor: 5.157

10.  Dual regulation of glycogen synthase kinase 3 (GSK3)α/β by protein kinase C (PKC)α and Akt promotes thrombin-mediated integrin αIIbβ3 activation and granule secretion in platelets.

Authors:  Samantha F Moore; Marion T J van den Bosch; Roger W Hunter; Kei Sakamoto; Alastair W Poole; Ingeborg Hers
Journal:  J Biol Chem       Date:  2012-12-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.